Speaking at the American Bar Association’s spring antitrust meeting Thursday, former Federal Trade Commission chairman Jon Leibowitz said he resisted pressure from the Democratic party to block corporate mergers as part of a political agenda. Leibowitz remarked that lawmakers in Congress expected the former chairman to block some mergers and singled out a particular case concerning pharmacy benefit mergers that earned criticism from politicians. Specifically, the merger between Express Scripts Inc. and its competitor Medco Health Solutions Inc., which combined two of the three leaders of the industry, was approved in April of last year by the FTC to the dismay of Congress; Leibowitz described the deal as an example of how the FTC resisted political pressure as lawmakers contacted the authority to block the merger.
Featured News
Meta Halts Commercial Terms Rollout After Publishers Raise Concerns in EU, UK
Oct 28, 2026 by
CPI
Nvidia’s $12.9 Billion Hugging Face Deal Draws Justice Department Questions
Oct 28, 2026 by
CPI
Rolls-Royce’s UltraFan Wins £2.5 Billion UK Framework Deal
Oct 28, 2026 by
CPI
Taiwan Blocks Grab’s $600 Million Foodpanda Deal, Citing Uber Ties
Oct 28, 2026 by
CPI
South Korea Expands Food Price-Fixing Probe to Four Major Instant Noodle Makers
Oct 28, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Exclusive Dealing
Oct 25, 2026 by
CPI
Exclusive Dealing Without Exclusivity: Screening Contracts, Loyalty Rebates, and the Limits of Antitrust Tests
Oct 25, 2026 by
David Martimort & Jérôme Pouyet
When Competition for Exclusivity Raises Prices: Rebates, Pricing Rules, and the Insulin Puzzle
Oct 25, 2026 by
Daniel P. O’Brien & Greg Shaffer
Why Leaving the Door Open Can Be (Much) Worse Than Closing It: Share-Based Requirements, Buyer-Specific Costs, and Foreclosure
Oct 25, 2026 by
Zhijun Chen & Greg Shaffer
Antitrust Chronicle® – EU Merger Guidelines
Oct 19, 2026 by
CPI